Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Motor Activity 249Breast Neoplasms 136Neoplasms 108Prostatic Neoplasms 35Fatigue 35Obesity 25Lung Neoplasms 24Colorectal Neoplasms 24Polycystic Ovary Syndrome 17Colonic Neoplasms 16Ovarian Neoplasms 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Pancreatic Neoplasms 11Lymphoma 11Lymphedema 11Hematologic Neoplasms 11Carcinoma, Non-Small-Cell Lung 11Weight Loss 10Rectal Neoplasms 10Multiple Myeloma 10Head and Neck Neoplasms 10Leukemia 9Cardiotoxicity 9Insulin Resistance 8Brain Neoplasms 8Stomach Neoplasms 7Peripheral Nervous System Diseases 7Overweight 6Esophageal Neoplasms 6Cognitive Dysfunction 6

Interventions

Carboplatin 7Trastuzumab 6Docetaxel 5pembrolizumab 4Paclitaxel 4Oxaliplatin 4Fluorouracil 4Cytarabine 4Cyclophosphamide 4Azacitidine 4pertuzumab 3Radiotherapy 3Observation 3Neoadjuvant Therapy 3Epirubicin 3Endoscopy 3Cisplatin 3Chemoradiotherapy 3Capecitabine 3venetoclax 2toripalimab 2sargramostim 2olaparib 2durvalumab 2cc-486 2Tretinoin 2Surgical Procedures, Operative 2Standard of Care 2Pemetrexed 2Monatide (IMS 3015) 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pathologic Complete Response × Exercise × Clear all
NCT07066189 2025-10-29

Lifestyle, Exercise, And Nutrition (LEAN) Trial on Pathologic Complete Response in TNBC

Yale University

Phase NA Recruiting
160 enrolled
Breast

Pathologic Complete Response, Motor Activity, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡